ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Pfizer Inc

Pfizer Inc (PFE)

23.32
0.28
(1.22%)
23.35
0.03
(0.13%)

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
23.35
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
35,499,472
22.88 Rango del Día 23.39
20.915 Rango de 52 semanas 31.54
Capitalización de Mercado [m]
Precio Anterior
23.04
Precio de Apertura
22.95
Última hora de negociación
Volumen financiero
US$ 824,351,877
Precio Promedio Ponderado
23.2215
Volumen promedio (3 m)
54,967,991
Acciones en circulación
5,685,365,587
Rendimiento del Dividendo
7.37%
Ratio Precio/Utilidad
16.51
Beneficio por acción (BPA)
1.41
turnover
63.63B
Beneficio neto
8.03B

Acerca de Pfizer Inc

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers includ... Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
New York, New York, USA
Fundado
-
Pfizer Inc is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker PFE. The last closing price for Pfizer was US$23.04. Over the last year, Pfizer shares have traded in a share price range of US$ 20.915 to US$ 31.54.

Pfizer currently has 5,685,365,587 shares in issue. The market capitalisation of Pfizer is US$130.99 billion. Pfizer has a price to earnings ratio (PE ratio) of 16.51.

Flujo de Opciones Pfizer (PFE)

Flujo General

Pesimista

Prima Neta

-2M

Calls / Puts

140.00%

Comp. / Vent.

88.57%

OTM / ITM

97.22%

Sweeps Ratio

4.17%

PFE Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.753.318584070822.623.722.454156225423.12751405CS
40.542.3673827268722.8124.4421.975073204923.18226615CS
12-2.74-10.502108087426.0927.2420.9155496799124.12356381CS
26-2.39-9.2851592851625.7427.5720.9154684848624.99432865CS
52-6.12-20.766881574529.4731.5420.9154057748126.50048273CS
156-29.15-55.523809523852.554.9320.9153248254832.14434555CS
260-14.41-38.162076271237.7661.7120.9153271365936.51628416CS

PFE - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Pfizer?
El precio actual de las acciones de Pfizer es US$ 23.35
¿Cuántas acciones de Pfizer están en circulación?
Pfizer tiene 5,685,365,587 acciones en circulación
¿Cuál es la capitalización de mercado de Pfizer?
La capitalización de mercado de Pfizer es USD 130.99B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Pfizer?
Pfizer ha negociado en un rango de US$ 20.915 a US$ 31.54 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Pfizer?
El ratio precio/beneficio de Pfizer es 16.51
¿Cuál es el ratio de efectivo a ventas de Pfizer?
El ratio de efectivo a ventas de Pfizer es 2.08
¿Cuál es la moneda de reporte de Pfizer?
Pfizer presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Pfizer?
El último ingresos anual de Pfizer es USD 63.63B
¿Cuál es el último beneficio anual de Pfizer?
El último beneficio anual de Pfizer es USD 8.03B
¿Cuál es la dirección registrada de Pfizer?
La dirección registrada de Pfizer es 235 EAST 42ND STREET, NEW YORK, NEW YORK, 10017
¿Cuál es la dirección del sitio web de Pfizer?
La dirección del sitio web de Pfizer es www.pfizer.com
¿En qué sector industrial opera Pfizer?
Pfizer opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
DOUGDouglas Elliman Inc
US$ 2.90
(35.51%)
14.35M
OKLOOklo Inc
US$ 48.87
(23.04%)
92.5M
XUS Steel Corp
US$ 52.17
(21.61%)
54.24M
GTN.AGray Media Inc
US$ 9.70
(21.40%)
2.54k
SMRNuScale Power Corporation
US$ 30.26
(19.51%)
48.86M
DECKDeckers Outdoor
US$ 101.05
(-19.86%)
19.58M
MNSOMINISO Group Holding Limited
US$ 18.285
(-17.60%)
9.19M
BAHBooz Allen Hamilton Holding Corporation
US$ 107.78
(-16.53%)
8.97M
WOLFWolfspeed Inc
US$ 1.445
(-15.50%)
68.97M
CNFCNFinance Holdings Limited
US$ 0.4753
(-11.65%)
87.87k
QBTSD Wave Quantum Inc
US$ 18.8099
(-1.21%)
148.39M
BBAIBigBear ai Holdings Inc
US$ 3.64
(-4.71%)
92.92M
OKLOOklo Inc
US$ 48.87
(23.04%)
92.5M
FFord Motor Company
US$ 10.355
(-0.81%)
80.51M
NUNu Holdings Ltd
US$ 11.99
(-2.12%)
77.29M

PFE Discussion

Ver más
Vexari Vexari 9 horas hace
Stepping out of the shadows

Risking everything

Careers, reputations, even life itself

To expose

What may be the largest crime against humanity in modern history
👎️ 1 💊 1 🗑️ 1 🤥 1 🤪 1
Vexari Vexari 10 horas hace
Truth is consistent
💊 1 💤 1 🤢 1
Monroe1 Monroe1 11 horas hace
Phuzzy PFE just can't get a break. Well maybe once in the cell culture....behind bars, they will have plenty of time to reflect on their diabolical manners. Opps, you crapped in your own mess kit.
https://www.globalresearch.ca/covid-vaccine-safe-effective-narrative-collapses-camera/5887991
🗑️ 1
Monroe1 Monroe1 1 día hace
Genocide and further more.... Edward Dowd, a financier focused on analyzing excess deaths data, has warned of a potential global demographic crisis if these findings hold true for humans. His comments have drawn attention to the need for further investigation into the vaccines’ effects on fertility. The study’s implications have sparked discussions among experts and policymakers alike.

The persistence of the spike protein, as observed in another study, has also raised safety concerns. Researchers have found that the protein can remain in the body for an extended period, prompting calls for more research. These findings have added to the growing list of questions about the long-term effects of COVID vaccines.

https://news.spreely.com/jim-jordan-investigates-pfizer-covid-vaccine-trials-amid-concerns-about-potential-impact-on-fertility/

Diving deeper we find the excavator way past asshole deep and decreasing the likelihood of ever climbing out. The company may well face being shut down.
👍️ 1
Monroe1 Monroe1 1 día hace
Karma yea buddy. Read em and weep. https://www.fiercepharma.com/pharma/fda-advisors-unanimously-snub-pfizers-bid-expand-talzenna-broader-prostate-cancer-population?oly_enc_id=4924G0643390I0A

Adding to my shorts. When to pull em up? Not sure, maybe at 12.
👍️0
Vexari Vexari 1 día hace
Genocide

Is not something

That can be dug out of
https://childrenshealthdefense.org/defender/pfizer-moderna-stronger-warnings-possible-heart-damage-covid-vaccines-fda/?utm_id=20250522
Has Bourla been banned and canned yet? If not, why not? Fuzzy Fizzer needs to do some years of volunteer work to restore their name. Tons of goodwill is called for. Will they ever dig out of the hole while earning respect?
🌚 1 👎️ 1 🗑️ 1 🤦 1
Monroe1 Monroe1 1 día hace
https://childrenshealthdefense.org/defender/pfizer-moderna-stronger-warnings-possible-heart-damage-covid-vaccines-fda/?utm_id=20250522
Has Bourla been banned and canned yet? If not, why not? Fuzzy Fizzer needs to do some years of volunteer work to restore their name. Tons of goodwill is called for. Will they ever dig out of the hole while earning respect?
👍️0
DewDiligence DewDiligence 4 días hace
PFE licenses Chinese PD-1xVEGF bispecific for $1.2B up-front and_total biobucks of $6.05B:

https://www.businesswire.com/news/home/20250519321225/en/Pfizer-Enters-into-Exclusive-Licensing-Agreement-with-3SBio Pfizer Inc. today announced it has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK), a leading Chinese biopharmaceutical company, for the development, manufacturing and commercialization of SSGJ-707, a bispecific antibody targeting PD-1 and VEGF, currently undergoing several clinical trials in China for non-small cell lung cancer, metastatic colorectal cancer, and gynecological tumors.

…3SBio and its subsidiaries Shenyang Sunshine Pharmaceutical Co., Ltd. and 3S Guojian Pharmaceutical (Shanghai) Co., Ltd. will grant Pfizer an exclusive global license to develop, manufacture and commercialize SSGJ-707 worldwide, excluding China. The agreement also provides Pfizer the option of commercialization rights in China. 3SBio will receive an upfront payment of $1.25 billion and is eligible to receive milestone payments associated with certain development, regulatory and commercial milestones up to $4.8 billion as well as tiered double-digit royalties on sales of SSGJ-707, if approved.

…Upon close, Pfizer will make a $100 million equity investment in 3SBio subject to an agreed upon securities subscription agreement between the parties. All told, this is a lot of money for a phase-2 asset (although phase-3 trials in China will be starting soon).
👍️ 1
Vexari Vexari 6 días hace
Fell into a burning ring of fire
Went down, down, down
As the flames went higher
And it burns, burns, burns
The ring of fire
🎃 1 👍️ 1 👎️ 2 💊 1 💯 1 🗑️ 2 🤪 1
Monroe1 Monroe1 1 semana hace
WSJ oh finally so common sense. So I want to know why the junk was ever allowed to be manufactured.
FDA Commissioner Marty Makary said Thursday, “I am not encouraging or insisting young, healthy children to get a Covid shot unless there is new evidence that emerges that suggests there is a clear benefit,” the WSJ reported.

A change in COVID-19 vaccine recommendations would mark a major departure from CDC policy over the last four years. However, it would be aligned with HHS Secretary Robert F. Kennedy Jr.’s long-held position that the COVID-19 vaccines pose serious safety risks for everyone, including children.
👍️0
Monroe1 Monroe1 1 semana hace
this is what is too sad... https://www.thefocalpoints.com/p/new-study-covid-19-vaccines-increase?r=x7hm
👍️0
Monroe1 Monroe1 1 semana hace
Bad Boy Burla doing the two-step. https://www.fiercepharma.com/pharma/house-committee-takes-over-probe-gsk-tip-allegations-pfizer-execs-may-have-conspired?oly_enc_id=4924G0643390I0A

Not good. Sanctions could come.
👍️0
Monroe1 Monroe1 1 semana hace
https://www.thefocalpoints.com/p/covid-19-vaccines-are-fueling-the?r=x7hm

The world wide rejection of spike protein injections is just ramping up. Wait for it!!!
The headwind against Pig Pharma will put them into the dust bin of history.
New era has emerged.
👍️0
biotech_researcher biotech_researcher 1 semana hace
Pharma Representative:
👍️ 1
DewDiligence DewDiligence 1 semana hace
PFE issues €3.3B of 4-20yr debt in four tranches:

https://www.sec.gov/Archives/edgar/data/78003/000119312525119917/d945917dfwp.htm
👍️0
BottomBounce BottomBounce 1 semana hace
🚨RFK Jr. implies COVID was engineered:

“Gain-of-function Research has no place in a civilized society. We cannot gamble with engineered pandemics in the name of ‘science’. We’re committed to ending reckless experiments that put Humanity at risk…” pic.twitter.com/uPhXvy5mhx— Died Suddenly (@DiedSuddenly_) May 14, 2025 $PFE
👍️ 1 👎️ 1 💯 1 🗑️ 1 🤪 1
Monroe1 Monroe1 1 semana hace
Interesting post. Thanks
I stay away from needles as do my pets.
👍️0
BottomBounce BottomBounce 1 semana hace
Not sure who needs to hear this, but pet vaccines are also dangerous.

Ever wonder why pets get cancer so often? pic.twitter.com/CvEBV8v8GD— Died Suddenly (@DiedSuddenly_) May 13, 2025 $PFE
👍️ 1
Monroe1 Monroe1 2 semanas hace
Amen, and the real rookies don't appreciate real news and the fact their is a new sheriff in town.
I have not lost any money in this stock but I have made money more than a half dozen time going short.
There is not a great future in this company right now. Too many lawsuits and a general hatred among the public.

Once that dust settles in a few years I will buy this turd should they dump all the executives and a few of them get their due in court. 35 years investing in pharmas and there has never been such a scam over the world such as they participated in. Ms.Karma can be a real bitch.
🗑️ 1
biotech_researcher biotech_researcher 2 semanas hace
Rookie..
👍️ 1
biotech_researcher biotech_researcher 2 semanas hace
Bullish that this is up on the drug tariff news. Mark this post. This was the bottom. Shortages galore.
👍️ 1 💯 1
BottomBounce BottomBounce 2 semanas hace
The COVID vaccine did not save lives. It took them. pic.twitter.com/YV9lcMTKUA— Died Suddenly (@DiedSuddenly_) May 10, 2025 $PFE
🃏 1 👍️ 2 👎️ 1 🕳️ 1 🗑️ 1 🤪 1
Vexari Vexari 2 semanas hace
This came to mind

Five stages of grief

Denial
Anger
Bargaining
Depression
Acceptance

Denial is a common reaction.

Those not paying attention

Can not believe
Lest we forget

" Small minds are easily amused"

And for all Fizer supporters hanging on to your dwindling holding, remember not to marry any stock that makes you sacrifice the better person inside.

“The only person you are destined to become is the person you decide to be.”
– Ralph Waldo Emerson
👍️ 1 👎️ 1 🗑️ 1 🤢 1 🤪 1
Monroe1 Monroe1 2 semanas hace
Denial is a common reaction.

Those not paying attention

Can not believe

Least we forget, " Small minds are easily amused"

And for all Fizer supporters hanging on to your dwindling holding, remember not to marry any stock that makes you sacrifice the better person inside.
“The only person you are destined to become is the person you decide to be.” – Ralph Waldo Emerson
👍️ 1
Vexari Vexari 2 semanas hace
Fallout numbers have been hidden

The pattern is coming to light

To what has actually been done

Those not paying attention

Can not believe

Dichotomy
👎️ 1 💊 1 🗑️ 1 🚽 1 🤥 1
Vexari Vexari 2 semanas hace
If money is what life is all about

God help you
👍️ 1 👎️ 2 🗑️ 2 🗣️ 1 🤪 1
biotech_researcher biotech_researcher 2 semanas hace
Cashflow machine..
👍️ 1
Monroe1 Monroe1 2 semanas hace
certainly not lately though. I am setting my sights on $13 the next Friday The 13th.
That's when I cover and then buy in long for some flipping more fun.
👎️ 1 🗑️ 1
Monroe1 Monroe1 2 semanas hace
The fallout from the kill shot will be felt and ongoing for many years to come.
It's not like it was a one time thing. This follows a pattern. Worse though are the
lingering spike proteins that are now taking a greater toll than initially. No more
gain of function crap allowed!! Signed Executive Order!!
👍️ 1 🗑️ 1 🤪 1
Vexari Vexari 2 semanas hace
No longer

Too big to fail

This road is full

Of unfulfilled potholes
👍️ 1 👎️ 1 🗑️ 1 😎 1 🙅 1 🚫 1 🤪 1
Vexari Vexari 2 semanas hace
Secured to a delusion

What makes it so?
🎃 1 👎️ 1 🗑️ 1 😎 1 🙅 1
biotech_researcher biotech_researcher 2 semanas hace
Dividend is secure..
👍️ 1
Monroe1 Monroe1 3 semanas hace
Gain of Function research banned!! A Fuzzy Fizer specialty along with Fauci. Wonder if CEO goofball Bourla and Dr.Falsi will be looking out from behind bars wondering if Big Bob is looking at them sweetly?
👍️ 1 👎️ 1 🗑️ 1 😂 1 🥳 1
Monroe1 Monroe1 3 semanas hace
https://kirschsubstack.com/p/five-recent-papers-show-vaccine-covid?publication_id=548354&post_id=162514310&isFreemail=true&r=x7hm&triedRedirect=true
👍️ 1 👎️ 1 💯 1 🗑️ 1 🤪 1
Monroe1 Monroe1 3 semanas hace
Bending over backwards to save Pig Pharma is the msm that promoted the crap jabs that killed more people worldwide than WW1 and 2 combined.
What's Phizer gonna do now?
https://www.thefocalpoints.com/p/breaking-trump-bans-foreign-gain#media-fe473cc9-7b8c-47ac-b31f-e6fa3973eca5

Gone below my buy in point. Good think I wasn't paying attention or I might have bot some.
Thinking now to just watch it keep plunging and see where the dust settles.
👍️ 1 😎 1
Vexari Vexari 3 semanas hace
Reality has a way

Of kicking one

In the ass
👎️ 1 🗑️ 1 😂 1 🤪 2
Vexari Vexari 3 semanas hace
What is cancer

Can it be defined
👎️ 1 🗑️ 1 🪠 1
Vexari Vexari 3 semanas hace
Truth

Is timeless

This is yesterday's news..

Monroe1

Re: None

Wednesday, April 30, 2025 6:21:59 PM

Post# 6885 of 6887

by Nicolas Hulscher, MPH

According to NBC, at least three major medical journals—CHEST, the New England Journal of Medicine (NEJM), and Obstetrics and Gynecology—have received letters from the U.S. Department of Justice questioning their editorial practices. The letters, sent by interim U.S. Attorney Ed Martin, raised legitimate concerns about bias, lack of transparency, and whether these journals fairly presented competing scientific viewpoints—especially on topics like COVID-19 policies and treatments. The consistent direction of bias was to suppress any new studies of combination early therapeutics and reports on poor efficacy and side effects of COVID-19 vaccines. Essentially, the journals became vaccine promotional vehicles. None of the major journals published manuscripts that concluded the risks outweigh the benefits of vaccination, despite more comprehensive papers published elsewhere arriving at the truth. As a result, the medical readership and public at large were duped into believing the COVID-19 vaccines were “safe and effective” yet nothing could be further from the truth. Here are two extensively referenced analyses that found COVID-19 vaccines were ineffective and unsafe for human use:
https://www.thefocalpoints.com/p/breaking-doj-launches-investigation?publication_id=1119676&post_id=162421212&isFreemail=true&r=x7hm&triedRedirect=true
🎃 1 👎️ 1 🗑️ 1
biotech_researcher biotech_researcher 3 semanas hace
This is yesterday's news..
👍️0
biotech_researcher biotech_researcher 3 semanas hace
Analysts appearing on CNBC are embracing pharma now.. finally. PFE is on the buy list
👍️0
Monroe1 Monroe1 3 semanas hace
by Nicolas Hulscher, MPH

According to NBC, at least three major medical journals—CHEST, the New England Journal of Medicine (NEJM), and Obstetrics and Gynecology—have received letters from the U.S. Department of Justice questioning their editorial practices. The letters, sent by interim U.S. Attorney Ed Martin, raised legitimate concerns about bias, lack of transparency, and whether these journals fairly presented competing scientific viewpoints—especially on topics like COVID-19 policies and treatments. The consistent direction of bias was to suppress any new studies of combination early therapeutics and reports on poor efficacy and side effects of COVID-19 vaccines. Essentially, the journals became vaccine promotional vehicles. None of the major journals published manuscripts that concluded the risks outweigh the benefits of vaccination, despite more comprehensive papers published elsewhere arriving at the truth. As a result, the medical readership and public at large were duped into believing the COVID-19 vaccines were “safe and effective” yet nothing could be further from the truth. Here are two extensively referenced analyses that found COVID-19 vaccines were ineffective and unsafe for human use:
https://www.thefocalpoints.com/p/breaking-doj-launches-investigation?publication_id=1119676&post_id=162421212&isFreemail=true&r=x7hm&triedRedirect=true
🎃 1 👍️ 1
Vexari Vexari 3 semanas hace
Too many unknown variables

Once they come to light

Katy bar the door
🎃 1 👎️ 1 💊 1 🗑️ 1 🤥 1
rosemountbomber rosemountbomber 3 semanas hace
Heck at a pe of 10 we should be at 30
👍️0
biotech_researcher biotech_researcher 3 semanas hace
PFE up AGAIN this AM in pre market as the rest of the market is in free fall.
👍️ 1
Vexari Vexari 3 semanas hace
What is it about a scam

That makes it proliferate
👍️ 1 👎️ 1 💤 1 🗑️ 1
DewDiligence DewDiligence 4 semanas hace
PFE reports 1Q25 results—reiterates 2025 guidance:

https://s28.q4cdn.com/781576035/files/doc_financials/2025/q1/Q1-2025-PFE-Earnings-Release-FINAL.pdf

1Q25 highlights

• 1Q25 revenue was $13.7B, -6% YoY†.

• 1Q25 oncology sales were $3.8B, +7% YoY†.

• 1Q25 Comirnaty and Paxlovid sales were $565M (+62% YoY†) and $491M (-75% YoY† due to fewer COVID infections in 1Q25 and a non-recurring revenue credit in 1Q24).

• 1Q25 Abrysvo sales were $131M, -6% YoY†.

• 1Q25 GAAP and non-GAAP EPS were $0.52 and $0.92, respectively.

† In constant currency.


2025 guidance for revenue and non-GAAP EPS remains as announced in Dec 2024 (#msg-175541136)—i.e. sales of $61-64B and non-GAAP EPS of $2.80-3.00.

PFE has not made any adjustment to 2025 guidance for the effect of tariffs that have yet to be implemented.


1Q25 CC slides:
https://s28.q4cdn.com/781576035/files/doc_financials/2025/q1/Q1-2025-Earnings-Charts-FINAL.pdf

1Q25 CC prepared remarks (synched with slides):
https://s28.q4cdn.com/781576035/files/doc_financials/2025/q1/Q1-2025-Earnings-Conference-Call-Prepared-Remarks-FINAL.pdf
👍️ 3
axelvento axelvento 4 semanas hace
$PFE Pfizer reported adjusted earnings per share (EPS) of $0.92, beating Wall Street expectations of $0.66 per share. Revenue came in at $13.7 billion, compared to the consensus of $14 billion.

Pfizer reaffirmed its 2025 outlook of $61 to $64 billion in revenue and adjusted earnings per share of $2.80 to $3.
👍️ 1 💯 2 🔝 2
biotech_researcher biotech_researcher 4 semanas hace
Outstanding quarterly results considering. Dividend is solid. 
👍️ 1
Monksdream Monksdream 4 semanas hace
PFE 10Q due Tuesday 4/29
👍️ 1
axelvento axelvento 4 semanas hace
Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

https://www.pfizer.com/news/press-release/press-release-detail/pfizers-sasanlimab-combination-significantly-improves-event?cid=tw_pbg_onco_aua-2025_0425&ttype=tw&linkId=806539624
👍️ 1 💯 2 🔜 1

Su Consulta Reciente

Delayed Upgrade Clock